NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-197-2023-0-PC-01 ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM4] PCT PCT PCT/US2023/069541 Pending
NIAID E-197-2023-1-PC-01 ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM5] PCT PCT PCT/US2023/069538 Pending
NEI E-076-2023-0-US-01 SHIPPING CONTAINER FOR SYSTEM SUPPORTING LIVE CELLS US 63/524,434 Expired
NCATS E-097-2023-0-US-01 POTENT AND SELECTIVE D3 ANTAGONISTS US 63/511,452 Expired
NIAID E-096-2023-0-US-01 NOVEL MALARIA VACCINE COMPRISING AMA1 AND RON2 ANTIGENS US 63/524,522 Expired
NIAID E-134-2020-1-US-01 ANTIBODY-GUIDED PCSK9-MIMICKING IMMUNOGENS LACKING 9-RESIDUE SEQUENCE OVERLAP WITH HUMAN PROTEINS US National Stage 18/270,436 Pending
NCI E-520-2013-0-US-03 HLA-A24 AGONIST EPITOPES OF MUC1-C ONCOPROTEIN AND COMPOSITIONS AND METHODS OF USE US CON 18/344,242 Pending
NINDS E-186-2023-0-US-01 Use of Iron Chelators for Treating Stuttering US 63/510,794 Expired
NCI E-132-2023-0-US-01 T CELL RECEPTORS TARGETING RAS WITH G12D, G12R, OR G12V MUTATION US 63/510,817 Expired
NCI E-158-2022-0-PC-01 IMMUNOGENS AND METHODS FOR INDUCING AN IMMUNE RESPONSE PCT PCT PCT/US2023/069057 Pending
NIAID E-055-2021-0-AU-01 Replication-Competent Adenovirus Type 4-SARS-CoV-2 Vaccines And Their Use AU National Stage 2022208035 Pending
NCI E-171-2020-0-AU-01 EXO VII Inhibitor and Quinolone Antibiotic Combination Useful for Treating Bacterial Infection AU National Stage 2021409956 Pending
NCI E-021-2023-0-US-01 PEPTIDE HYDROGEL COMPRISING HYDROPHILIC AZIDE-CONTAINING AMINO ACID AND
ITS USE 		US ORD 18/340,863 Pending
NEI E-013-2021-0-AU-01 COMPOSITION AND METHOD OF PRESERVING VIABILITY OF CELL IN A LOW TEMPERATURE AU National Stage 2021400321 Pending
NIBIB E-237-2020-0-EP-01 Systems and Methods for Producing Isotropic In-Plane Super-Resolution Images from Line-Scanning Confocal Microscopy EP National Stage 22737121.8 Pending
NEI E-293-2016-0-AU-01 TISSUE CLAMP AND IMPLANTATION METHOD AU DIV 2023203954 Pending
NCI E-171-2020-0-CN-01 EXO VII Inhibitor and Quinolone Antibiotic Combination Useful for Treating Bacterial Infection CN National Stage 202180086835.1 Pending
NCI E-088-2020-0-HK-01 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION HK EP 62023074794.6 Pending
NCI E-171-2020-0-US-02 EXO VII Inhibitor and Quinolone Antibiotic
Combination Useful for Treating Bacterial Infection 		US National Stage 18/268,603 Pending
NEI E-013-2021-0-CA-01 COMPOSITION AND METHOD OF PRESERVING VIABILITY OF CELL IN A LOW TEMPERATURE CA National Stage 3202729 Pending
NEI E-013-2021-0-US-02 COMPOSITION AND METHOD OF PRESERVING VIABILITY OF CELL IN A LOW TEMPERATURE US National Stage 18/258,125 Pending
NCI E-202-2020-0-EP-01 TYROSYL-LOCK PEPTIDES EP National Stage 21840215.4 Pending
NIAID E-021-2021-0-EP-01 NOVEL VAR2CSA IMMUNOGENS AND METHODS OF USE THEREOF EP National Stage 21830553.0 Pending
NIAID E-001-2024-0-PC-01 Viral Strain Serology Assays PCT PCT PCT/US2023/068614 Pending
NIBIB E-007-2021-0-CN-01 ANTIBODY SPECIFIC FOR SARS]COV]2 RECEPTOR BINDING DOMAIN AND THERAPEUTIC METHODS CN National Stage 202180084270.3 Pending
NCI E-067-2017-0-CN-01 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES CN DIV 202310701331.7 Pending
NCI E-089-2023-0-US-01 EPIDITHIODIKETOPIPERAZINE ANALOGS AND METHODS OF USE US 63/507,813 Expired
NIAAA E-110-2022-0-PC-01 METABOTROPIC GLUTAMATE RECEPTOR 5 ANTAGONISTS COMPOSITIONS AND METHODS FOR THE TREATMENT OF FIBROSING PULMONARY DISEASES PCT PCT PCT/US2023/025047 Pending
NIAID E-228-2016-1-IL-01 Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof IL DIV 303650 Pending
NIAID E-055-2021-0-CA-01 Replication-Competent Adenovirus Type 4-SARS-CoV-2 Vaccines And Their Use CA National Stage 3205052 Pending
NCI E-171-2020-0-CA-01 EXO VII Inhibitor and Quinolone Antibiotic Combination Useful for Treating Bacterial Infection CA National Stage 3205044 Pending
NCI E-147-2021-0-US-02 COMPOSITIONS AND METHODS FOR TREATING CANCER US National Stage 18/266,455 Pending
NHLBI E-111-2022-2-PC-01 Real-time AI System For Echocardiography Analysis And Quantification PCT PCT COMB PCT/US2023/024902 Pending
NIEHS E-184-2023-0-US-01 METHOD AND APPARATUS FOR CRYOGENIC-ELECTRON MICROSCOPY SAMPLE PREPARATION US 63/472,113 Expired
NCI E-174-2018-2-JP-01 CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer JP DIV 2022-135735 Pending
NCI E-121-2022-0-PC-01 COMPOSITIONS, SYSTEMS, AND METHODS FOR DELIVERY OF THERAPEUTICS PCT PCT PCT/US2023/068139 Pending
NHLBI E-197-2020-0-EP-01 SINGLE-CELL PROFILING OF CHROMATIN OCCUPANCY AND RNA SEQUENCING EP National Stage 21892742.4 Pending
NCATS E-156-2022-0-PC-01 COMPOUNDS FOR INHIBITING GRAM-POSITIVE BACTERIA PCT PCT PCT/US2023/068040 Pending
NIDDK E-160-2022-0-PC-01 COMPOSITIONS AND METHODS FOR PHARMACOLOGIC TREATMENT OF STROKE AND MYOCARDIAL ISCHEMIA REPERFUSION INJURY PCT PCT PCT/US2023/024676 Pending
NCI E-013-2018-0-US-04 Compositions and Methods for Treating Cancer with Anti-CD19 Immunotherapy US DIV 18/330,587 Pending
NIAID E-057-2011-2-US-07 VIRUS-LIKE PARTICLES AND METHODS OF USE US DIV 18/331,083 Pending
NCI E-186-2022-0-PC-01 PREDICTING PATIENT RESPONSE TO CANCER THERAPY VIA HISTOPATHOLOGY IMAGES PCT PCT PCT/US2023/024571 Pending
NCI E-074-2020-1-HK-01 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION HK EP 62023074121.2 Pending
NCI E-031-2020-0-HK-01 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12D MUTATION HK EP 62023074114.7 Pending
NCATS E-006-2022-0-PC-01 LATS INHIBITORS AND USES THEREOF PCT PCT PCT/US2023/024589 Pending
NCI E-176-2014-0-JP-01 ANTI-HUMAN PAPILLOMAVIRUS 16 E7 T CELL RECEPTORS JP DIV 2023-091878 Issued
NIAID E-193-2021-0-PC-01 ENGINEERED CELL-PENETRATING ANTIVIRAL COMPOUND PCT PCT PCT/US2023/067856 Pending
NIAID E-137-2018-2-JP-01 Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response JP DIV 2023-91864 Pending
NIAID E-118-2023-2-US-01 VACCINE FOR CATS TO BLOCK TOXOPLASMA OOCYST SHEDDING AND TRANSMISSION US 63/470,773 Expired
NCI E-067-2017-0-EP-01 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES EP DIV 23176735.1 Pending